Addex Revises Share-sale Agreement With H.C. Wainwright

MT Newswires · 3d ago
06:14 AM EST, 12/11/2025 (MT Newswires) -- Addex Therapeutics (ADXN.SW) said Thursday it updated its at-the-market share issuance arrangement with H.C. Wainwright, keeping in place the option to sell up to $3.3 million in American Depositary Shares when market conditions allow. Any sales would be made under the Swiss clinical-stage biopharmaceutical company's existing US registration and carried out at its discretion, with the bank acting as agent and earning a 3% commission on proceeds.